ALTERNATIVE STAINING OF FASCIOLA GIGANTICA USING NATURAL HERBAL DYES
نویسندگان
چکیده
منابع مشابه
Determination of somatic and excretory-secretory antigens of Fasciola hepatica and Fasciola gigantica using SDS-PAGE
Human fascioliasis due to unknown species and animal fascioliasis caused by both or one of Fasciola spp. are commonly seen in Iran. To compare electrophoretic patterns of somatic and excretory-secretory antigens of F. hepatica and F. gigantica by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), the adult flukes were collected from infected slaughtered bovine livers. E/S a...
متن کاملCholestasis caused by Fasciola gigantica.
Fascioliasis is an infectious disease caused by the hepatic trematodes Fasciola hepatica and Fasciola gigantica. Here, we report the case of Fasciola gigantica presenting with biliary obstruction and abdominal pain that was diagnosed and treated by endoscopic retrograde cholangiography (ERCP). A 46-year-old woman presented with right upper quadrant abdominal pain and jaundice. Physical examinat...
متن کاملFasciola gigantica: immunization of rabbits with proteins isolated from coproantigen.
Two fractions were isolated from coproantigen by ion-exchange chromatography in which DEAE cellulose was utilized. Both fractions and crude antigen were characterized by SDS-polyacrylamide gel electrophoresis which revealed 13 bands of molecular weight ranged from 205-31 in crude coproantigen. While fraction I resolved into six bands of molecular weight 198, 178, 148, 111, 101 & 45. Fraction II...
متن کاملAnthelmintic Potential of Thymoquinone and Curcumin on Fasciola gigantica
Fasciolosis an economically important global disease of ruminants in the temperate and tropical regions, caused by Fasciola hepatica and F. gigantica, respectively, also poses a potential zoonotic threat. In India alone it causes huge losses to stakeholders. Anthelmintics including triclabendazole have been used to control this menace but the emerging resistance against the available compounds ...
متن کاملHerbal COX-2 Inhibitors: A Natural Alternative
n Sept. 30, 2004, the pharmaceutical giant Merck & Co. Inc. announced a voluntary worldwide withdrawal of VIOXX (rofecoxib), its arthritis and acute pain COX-2 inhibiting medication. The company’s decision was based on data from a new, three-year prospective, randomized, placebo-controlled clinical trial, which showed that after 18 months of use, VIOXX increased relative risk for confirmed card...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Egyptian Society of Parasitology
سال: 2020
ISSN: 2090-2549
DOI: 10.21608/jesp.2020.88809